// App-Quantinova.ai

2691436 : Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapy for Neovascular Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME) in Routine Clinical Practice

Researchers

Presenter

  • John D Pitcher

Principal Investigators

  • Andrew A Moshfeghi

  • Genevieve Lucas

  • Nick Boucher

  • Namrata Saroj

Medical Centers

  • Vestrum Health, Ottawa, Ontario, Canada

  • Vision Research Center, Eye Associates of New Mexico, Albuquerque, New Mexico, United States

  • Department of Surgery, Division of Ophthalmology, University of New Mexico, Albuquerque, New Mexico, United States

  • Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States

  • Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Ophthalmology (OP)

Disease

  • N/A

Biomarkers

  • Adenosylmethionine Decarboxylase 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved